|Articles|June 1, 2019
- BioPharm International-06-01-2019
- Volume 43
- Issue 6
BioPharm International, June 2019 Issue (PDF)
Click the title above to open the BioPharm International June 2019 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 6 years ago
FDA Advances New Approach to Drug Quality Assessmentover 6 years ago
Bio/Pharma Facilities Still Have a Lot to Learnover 6 years ago
Moving PAT from Concept to Realityover 6 years ago
Streamlining Upstream Processing: A Good Place to Startover 6 years ago
On the Right Trackover 6 years ago
Quality Agreements and Out-of-Specification Investigationsover 6 years ago
Addressing the Complex Nature of Downstream Processing with QbDover 6 years ago
From Data to InformationNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Developing Next-Gen Cell Lines Using Targeted Integration
2
Norgine Secures Hepatitis Delta Therapy Rights Across Key Region
3
FDA-Approved WAS Gene Therapy Hits Market in Nonprofit Model
4
EU Clears Subcutaneous Biologic for Lupus, Advancing Patient-Controlled Delivery
5
